Through gene expression profiling, comparison-ontology analyses and subsequent functional studies, FBLN5 was confirmed as a synthetic lethality partner of MYC, causing selective downregulation of MYC-dependent genes in COS-7 cells and inducing MYC-specific cell death in COS-7 and MCF-7 breast cancer cells. The gene discussed is MYC; the disease is breast carcinoma.